Kannan Sudha

Kannan Sudha

Active Director Director DIN 08033785
DIN 08033785 First appointment Feb 2018 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2018
Shareholding value •••• Premium profile

About Kannan Sudha

Data last updated:

Kannan Sudha is a Director at Synflix Pharmaceutical Private Limited (since 2018). The company operates in Pharma. Synflix Pharmaceutical Private Limited reported revenue of ₹63.5 Lakh (FY 2025).

DIN 08033785
Primary Designation Director
Industry Pharma
First Appointment 15 Feb 2018
Oldest Company Age 8 yrs
Largest company Synflix Pharmaceutical Private Limited · ₹63.5 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 Feb 20182018₹63.5 Lakh (FY 2025)Active

Board colleagues of Kannan Sudha

NameDINCompanyDesignation
Arunachalam Lakshmi08033787Synflix Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Synflix Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Kannan Sudha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kannan Sudha

Kannan Sudha currently holds 1 directorship: Synflix Pharmaceutical Private Limited (Director, since 15 Feb 2018, revenue ₹63.5 Lakh (FY 2025)).

Kannan Sudha was first appointed on 15 Feb 2018 as Director at Synflix Pharmaceutical Private Limited.

The current boards of Kannan Sudha's companies include Arunachalam Lakshmi (Synflix Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available